The Impact of COVID-19 Confinement on Tinnitus and Hearing Loss in Older Adults: Data From the LOST in Lombardia Study.

COVID-19 cross-sectional study hearing loss older adults tinnitus

Journal

Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899

Informations de publication

Date de publication:
2022
Historique:
received: 17 01 2022
accepted: 07 02 2022
entrez: 25 3 2022
pubmed: 26 3 2022
medline: 26 3 2022
Statut: epublish

Résumé

Although a direct relationship between tinnitus or hearing difficulties and COVID-19 has been suggested, current literature provides inconsistent results, and no research has been undertaken in older adults. In November 2020, we conducted the LOST in Lombardia survey, a telephone-based cross-sectional study on a sample of 4,400 individuals representative of the general population aged ≥65 years from Lombardy region, Northern Italy. Individuals with diagnosed tinnitus and/or hearing loss were asked whether their conditions had improved or deteriorated in 2020 compared to 2019. Overall, 8.1% of older adults reported a diagnosis of tinnitus and 10.5% of hearing loss. In 2020 compared to 2019, among individuals with tinnitus, those with increasing severity (5.0%) were similar to those decreasing it (5.3%). Among individuals with hearing loss, more people reported an increase (13.6%) than a decrease (3.2%) in their disease severity. No individual with a diagnosis in 2020 of tinnitus ( In this large representative sample of older adults, on average neither COVID-19 confinement nor SARS-CoV-2 infection appeared to increase the severity or incidence of tinnitus. The increased severity of hearing difficulties may totally or partially be explained by physiologic deterioration of the condition, or by a misperception due to the use of face-masks.

Sections du résumé

Background UNASSIGNED
Although a direct relationship between tinnitus or hearing difficulties and COVID-19 has been suggested, current literature provides inconsistent results, and no research has been undertaken in older adults.
Methods UNASSIGNED
In November 2020, we conducted the LOST in Lombardia survey, a telephone-based cross-sectional study on a sample of 4,400 individuals representative of the general population aged ≥65 years from Lombardy region, Northern Italy. Individuals with diagnosed tinnitus and/or hearing loss were asked whether their conditions had improved or deteriorated in 2020 compared to 2019.
Results UNASSIGNED
Overall, 8.1% of older adults reported a diagnosis of tinnitus and 10.5% of hearing loss. In 2020 compared to 2019, among individuals with tinnitus, those with increasing severity (5.0%) were similar to those decreasing it (5.3%). Among individuals with hearing loss, more people reported an increase (13.6%) than a decrease (3.2%) in their disease severity. No individual with a diagnosis in 2020 of tinnitus (
Conclusions UNASSIGNED
In this large representative sample of older adults, on average neither COVID-19 confinement nor SARS-CoV-2 infection appeared to increase the severity or incidence of tinnitus. The increased severity of hearing difficulties may totally or partially be explained by physiologic deterioration of the condition, or by a misperception due to the use of face-masks.

Identifiants

pubmed: 35330807
doi: 10.3389/fneur.2022.838291
pmc: PMC8940241
doi:

Types de publication

Journal Article

Langues

eng

Pagination

838291

Investigateurs

Silvano Gallus (S)
Cristina Bosetti (C)
Carlotta Micaela Jarach (CM)
Alessandra Lugo (A)
Chiara Stival (C)
Gianluca Serafini (G)
Andrea Amerio (A)
Mario Amore (M)
David Stuckler (D)
Roberto De Sena (R)
Simone Ghislandi (S)
Yuxi Wang (Y)
Licia Iacoviello (L)
Marialaura Bonaccio (M)
Francesco Gianfagna (F)
Anna Odone (A)
Carlo Signorelli (C)
Giansanto Mosconi (G)
Giacomo Vigezzi (G)
Luca Cavalieri d'Oro (L)
Magda Rognoni (M)
Luca Paroni (L)
Alberto Zucchi (A)
Roberta Ciampichini (R)

Informations de copyright

Copyright © 2022 Jarach, Lugo, Stival, Bosetti, Amerio, Cavalieri d'Oro, Iacoviello, Odone, Stuckler, Zucchi, van den Brandt, Garavello, Cederroth, Schlee, Gallus and the LOST in Lombardia Study Investigators.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Acta Biomed. 2020 Jul 20;91(9-S):87-89
pubmed: 32701921
Curr Top Behav Neurosci. 2021;51:3-28
pubmed: 32840860
Ear Nose Throat J. 2021 Apr;100(2_suppl):152S-154S
pubmed: 32755405
J Affect Disord. 2021 Sep 1;292:398-404
pubmed: 34139414
G Ital Cardiol (Rome). 2020 Oct;21(10):750-756
pubmed: 32968307
Int J Immunopathol Pharmacol. 2021 Jan-Dec;35:20587384211027373
pubmed: 34142589
Can J Neurol Sci. 2022 Mar;49(2):184-195
pubmed: 33843530
Lancet. 2013 Nov 9;382(9904):1600-7
pubmed: 23827090
Int J Audiol. 2021 Jul 28;:1-6
pubmed: 34319825
Lancet Public Health. 2020 May;5(5):e253
pubmed: 32220653
PLoS One. 2021 Feb 5;16(2):e0246328
pubmed: 33544744
Front Neurol. 2021 Aug 04;12:707207
pubmed: 34421805
Front Public Health. 2020 Nov 05;8:592878
pubmed: 33251179
J Surg Oncol. 2021 Jan;123(1):24-31
pubmed: 33084056
Eur Arch Otorhinolaryngol. 2021 Nov 5;:
pubmed: 34739577
Acta Biomed. 2020 Nov 20;91(4):e2020195
pubmed: 33525234
Stat Methods Appt. 2021 May 20;:1-15
pubmed: 34035795
J Neurosci Res. 2020 Sep;98(9):1705-1720
pubmed: 32557661
J Eur Acad Dermatol Venereol. 2021 Nov;35(11):e714-e715
pubmed: 34236721
Lancet Public Health. 2020 Oct;5(10):e543-e550
pubmed: 32979305
Int J Audiol. 2021 Aug 9;:1-9
pubmed: 34370603
Lancet Reg Health West Pac. 2021 Mar 24;9:100131
pubmed: 34327440
J Clin Med. 2021 Jun 23;10(13):
pubmed: 34201831
Graefes Arch Clin Exp Ophthalmol. 2020 Dec;258(12):2655-2660
pubmed: 32960319
Laryngoscope. 2017 Feb;127(2):466-469
pubmed: 27301552
Hear Res. 2016 Jul;337:70-9
pubmed: 27246985
J Clin Med. 2020 Aug 26;9(9):
pubmed: 32858835

Auteurs

Carlotta Micaela Jarach (CM)

Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Alessandra Lugo (A)

Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Chiara Stival (C)

Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Cristina Bosetti (C)

Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Andrea Amerio (A)

Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), Section of Psychiatry, University of Genoa, Genoa, Italy.
IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

Luca Cavalieri d'Oro (L)

ATS della Brianza, Monza, Italy.

Licia Iacoviello (L)

Research Center in Epidemiology and Preventive Medicine (EPIMED), Department of Medicine and Surgery, University of Insubria, Varese, Italy.
Department of Epidemiology and Prevention, IRCCS Neuromed, Pozzilli, Italy.

Anna Odone (A)

School of Medicine, University Vita-Salute San Raffaele, Milan, Italy.
Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia, Italy.

David Stuckler (D)

Department of Social Sciences and Politics, Bocconi University, Milan, Italy.

Alberto Zucchi (A)

ATS di Bergamo, Bergamo, Italy.

Piet van den Brandt (P)

Department of Epidemiology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, Netherlands.
Department of Epidemiology, CAPHRI-School for Public Health and Primary Care, Maastricht University Medical Centre, Maastricht, Netherlands.

Werner Garavello (W)

Department of Otorhinolaryngology, School of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy.

Christopher R Cederroth (CR)

Laboratory of Experimental Audiology, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Nottingham Biomedical Research Centre, National Institute for Health Research (NIHR), Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.
Division of Clinical Neuroscience, Hearing Sciences, School of Medicine, University of Nottingham, Nottingham, United Kingdom.

Winfried Schlee (W)

Department of Psychiatry and Psychotherapy, University Regensburg, Regensburg, Germany.

Silvano Gallus (S)

Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Classifications MeSH